Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Market Cap	103.38B
Revenue (ttm)	6.63B
Net Income (ttm)	1.42B
Shares Out	102.64M
EPS (ttm)	13.81
PE Ratio	72.93
Forward PE	55.50
Dividend	1.00 (0.10%)
Ex-Dividend Date	Aug 30, 2024

Volume	215,992
Average Volume	2,854,941
Open	1,004.50
Previous Close	1,002.15
Day's Range	998.70 - 1,017.95
52-Week Range	636.60 - 1,275.00
Beta	-0.10
RSI	47.03
Earnings Date	May 8, 2025

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 an...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 2,053
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIJAYA

Financial Performance

In 2023, Vijaya Diagnostic Centre's revenue was 5.48 billion, an increase of 19.29% compared to the previous year's 4.59 billion. Earnings were 1.19 billion, an increase of 40.40%.